Saving the Lives of People with Blood Cancer
by
Here, Anthony Nolan’s Chief Executive, Henny Braund, gives an overview of current and emerging treatments for blood cancer and the developments needed to give patients the best chance of life. This blog post is adapted from an interview recently given by Henny Braund for The Economist’s World Cancer Series: Europe Virtual Week. You can watch…
by
Umbilical cord blood (UCB) has huge potential, not only as a successful alternative source of hematopoietic blood cells for transplant/clinical application, but in research and development too. However, too often UCB is overlooked and seen as just an alternative, leaving it an under-utilised resource. UCB in transplantation The advantages of UCB as a source of…
by
For over 45 years Anthony Nolan has recruited potential stem cell donors to their register – people who are willing to donate their cells to someone in need of a lifesaving stem cell transplant. As this work continues, in parallel we apply our vast experience and dedicated team of experts to help develop new cell-based…
by
Cell and gene therapies have the potential to be transformative for patients. With the right support, researchers and developers have an opportunity to become leaders in this competitive global market. The number of allogeneic cell-based therapies in development is greater than ever, but how can organisations ensure they have a sustainable supply of starting material?…
by
In this blog, our Science Communications Manager, Jonathan Kay, looks at a recent study that highlights the potential benefits of selecting a cord blood transplant over a matched related donor for some patients with blood cancer. Introduction When someone needs a stem cell transplant to treat their blood cancer or blood disorder, they can rely on organisations like…
by
Against daily news articles on COVID-19’s impact and possible new treatments or vaccines, it can be very hard to get a clear picture of the research landscape around the virus. Here Anthony Nolan’s Dr Jonathan Kay summarises the medical research underway to improve our understanding of COVID-19 and examines how it affects patients with blood cancer. Jonathan also talks about IMPACT’s COVID-19 clinical trial for stem cell transplant patients which is part funded by Anthony…
